Literature DB >> 15448493

The epidemiology of diffuse lamellar keratitis.

R Doyle Stulting1, J Bradley Randleman, Jane M Couser, Keith P Thompson.   

Abstract

PURPOSE: To report the incidence and outcomes of diffuse lamellar keratitis (DLK) after LASIK and to analyze potential causative factors.
METHODS: Retrospective review of 15,119 cases (11,232 primary procedures and 3887 enhancements) from 7168 patients undergoing LASIK from May 1995 through October 2002, comparing preoperative data and postoperative outcomes for each case developing DLK to patients in the study population and a control series of eyes that did not develop DLK.
RESULTS: We identified 61 eyes (0.40%) that developed DLK after LASIK. Three study groups were identified based on sterilization protocols used: (1) steam autoclave without reservoir (8348 cases), (2) cassette autoclave with reservoir (6771 cases), (3) steam autoclave without reservoir and new instrument cleaner (1758 cases). Significantly more eyes developed DLK with Protocol 2 (47 cases, 0.94%) than with Protocol 1 (11 cases; 0.1%; P < 0.0001) or Protocol 3 (3 cases, 0.2%; P < 0.0005). There was no significant difference in the incidence of DLK in Protocol 1 versus Protocol 3. DLK was significantly more common after primary procedures than with enhancement procedures only under Protocol 2. No individual developed DLK after more than 1 procedure. Treatment protocols included frequent topical steroids only (24 cases, 39.3%), frequent topical steroids and oral steroids (19 cases, 31.2%), or topical and oral steroids combined with lifting and irrigating beneath the flap (18 cases, 29.5%). Final refractions and visual acuities were not significantly different in eyes that developed DLK and those that did not.
CONCLUSIONS: DLK is a nonspecific inflammatory response to multiple stimuli that cannot be attributed solely to individual variation in the inflammatory response, the microkeratome, or material deposited by the microkeratome. Sterilizers with reservoirs may cause some cases of DLK. With appropriate diagnosis and treatment, DLK should resolve without sequelae, yielding visual outcomes comparable to cases with uneventful postoperative courses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448493     DOI: 10.1097/01.ico.0000127477.14304.de

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Incidence of diffuse lamellar keratitis after LASIK with 15 KHz, 30 KHz, and 60 KHz femtosecond laser flap creation.

Authors:  Christina H Choe; Carly Guss; David C Musch; Leslie M Niziol; Roni M Shtein
Journal:  J Cataract Refract Surg       Date:  2010-11       Impact factor: 3.351

Review 2.  LASIK interface complications: etiology, management, and outcomes.

Authors:  J Bradley Randleman; Rupa D Shah
Journal:  J Refract Surg       Date:  2012-08       Impact factor: 3.573

3.  Diagnosis, Clinical Trend, and Treatment of Diffuse Lamellar Keratitis after Femtosecond Laser-Assisted in situ Keratomileusis: A Case Report.

Authors:  Angelo Balestrazzi; Alessandra Balestrazzi; Maria Ilaria Giannico; Paolo Michieletto; Emilio Balestrazzi
Journal:  Case Rep Ophthalmol       Date:  2018-11-14

4.  Urrets-Zavalia syndrome with interface fluid syndrome following laser in situ keratomileusis.

Authors:  Alfonso Vasquez-Perez; Francesco Aiello; Kirithika Muthusamy; Stephen Tuft
Journal:  Am J Ophthalmol Case Rep       Date:  2018-12-18

Review 5.  Keratitis following laser refractive surgery: Clinical spectrum, prevention and management.

Authors:  Shilpa Das; Prashant Garg; Ritika Mullick; Sriram Annavajjhala
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

6.  The effect of diffuse lamellar keratitis on visual acuity and contrast sensitivity following LASIK.

Authors:  Eui Seok Han; Won Ryang Wee; Jin Hak Lee; Mee Kum Kim
Journal:  Korean J Ophthalmol       Date:  2007-03

7.  Late-onset diffuse lamellar keratitis 4 years after femtosecond laser-assisted small incision lenticule extraction: a case report.

Authors:  Meiyan Li; Dong Yang; Yingjun Chen; Meng Li; Tian Han; Xingtao Zhou; Katherine Ni
Journal:  BMC Ophthalmol       Date:  2017-12-08       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.